The IPO window is open—but November’s real test is liquidity

The U.S. capital-raising window has widened substantially, but a strong issuance tally does not tell us whether new shares can be absorbed smoothly. The near-term calendar is thin, technology risk appetite has been shaken, and the filing of a potential mega-IPO has put allocation, float and future supply back in focus. The balanced reading: the public market can finance growth, but the capacity to absorb supply remains conditional on demand and trading depth.

A strong first half, followed by a pause

The SEC’s latest reported first-half data show 208 IPOs raising more than $137 billion in H1 2026, versus 180 IPOs and more than $27 billion in the year-earlier period. Follow-on registered offerings also increased: 557 deals raised over $111 billion, compared with 505 offerings and nearly $84 billion in H1 2025. That is meaningful growth in both new listings and existing issuers’ access to capital, but proceeds can be concentrated in a few large transactions; deal count and dollars alone do not measure secondary-market depth or aftermarket quality.^[1]

The immediate calendar looks much less crowded. As of November 2, Renaissance Capital listed one scheduled U.S. IPO for the week—a $100 million SPAC—and no public listings scheduled to price afterward. It noted that smaller deals could still join the calendar, and that filed issuers could launch if conditions allowed. Six lock-up periods were due to expire during the week, a reminder that public float can expand through resales as well as primary offerings.^[2][3]

That gap between a busy half-year and a quiet week is not a contradiction. Issuance is cyclical and deal timing is discretionary. A thin calendar can mean companies are waiting for clearer conditions; it does not, by itself, establish that the market has closed.

Anthropic’s filing is a test of appetite, not a priced deal

Anthropic said on October 26 that it had filed a registration statement for a proposed Nasdaq IPO under the symbol ANT. The company’s announcement explicitly said the share count and price range had not yet been determined, and that the registration statement was not yet effective. Therefore, this is a significant pipeline signal—not a completed offering, confirmed timetable, or verified deal valuation.^[4]

The distinction matters for market structure. A large prospective listing can attract investor attention and compete for risk capital, but only the final prospectus, deal size, allocation and subsequent trading can show how much supply actually reaches public investors and how the market absorbs it. Media estimates are not company-announced terms and should not be treated as such.

Supply needs a buyer—and the buyers are not interchangeable

Buybacks can offset some market supply, but their scale and timing vary. AutoNation reported that it repurchased $620 million of stock year-to-date through Q3, reducing shares outstanding by 9%, and that its board approved an additional $1 billion authorization. That is a company-specific example of demand for its own shares, not proof that buybacks will absorb IPOs or follow-ons across the market.^[5]

There is also a counter-signal in technology. Reuters reported that the largest U.S. technology companies returned the smallest share of their cash to shareholders in at least 15 years during the first nine months of 2026, as AI investment absorbed more cash. That does not mean buybacks have disappeared, but it cautions against assuming that headline corporate cash balances automatically translate into near-term equity demand.^[6]

Market conditions added another test at October’s end: the Nasdaq fell 2.9% on October 30 after disappointing results from large technology companies intensified concerns around the AI trade. That is relevant to a high-profile AI listing and AI-infrastructure financing stories, but it is not evidence that the proposed offering will fail. It does raise the bar for investors to distinguish durable customer demand from the financing and capacity costs required to serve it.^[7]

Market plumbing is changing at the proposal stage

The market-structure debate is not limited to IPO allocations. In June, the SEC proposed changes to Regulation NMS concerning the trade-through rule and locked or crossed markets. These are proposals, not adopted changes; until the rulemaking proceeds, they should be treated as a possible future change to routing and execution incentives, not today’s operating rules.^[8]

Separately, an October SEC proposal would expand certain registered-fund cross-trading permissions to additional Level 2 securities, with pricing and oversight guardrails. Commissioner Mark Uyeda’s statement described the potential role of cross-trading in avoiding distressed sales in thin markets, while also raising the value of transaction-level transparency for price discovery. This concerns registered funds and primarily fixed-income liquidity; it is not a direct mechanism for absorbing IPO shares. The broader lesson is that liquidity depends on both willing capital and the rules and transparency governing how securities trade.^[9]

The SEC’s October staff paper on reducing the round lot is another market-quality item to track, but the material retrieved for this review established its publication rather than the paper’s empirical conclusions. No directional claim about its effects is warranted here.^[10]

What the operating evidence says about the growth thesis

The scope for this review includes DDOG, SNOW, CRWV, AN, RH, WSM, ETH and LZB. These are not one market or one earnings cycle. Recent company disclosures offer a useful check on whether growth and demand can support the broader risk appetite that new issuance requires—but they do not answer the liquidity question alone.

The hypothesis that earnings growth and resilient demand can support these names over the coming year has partial support, not a blanket confirmation. DDOG and SNOW have recent reported growth; WSM’s latest located quarter points to stronger comparable demand. CRWV has described strong AI-cloud demand, but capital intensity creates a different funding test. AutoNation’s repurchases coexist with weaker year-over-year EPS; RH’s revenue growth came alongside a reported tariff benefit; and the LZB observation is older. The evidence is mixed by business model and recency.

A practical checklist for reading issuance and liquidity

What to watch next

• Whether the sparse November IPO calendar fills in, and whether newly scheduled deals are priced and trade without relying on unsupported assumptions about demand.
• Anthropic’s subsequent SEC filings for a price range, offered share count, effectiveness status and any confirmed timetable. None of those terms was established in the company’s initial filing announcement.
• The six lock-up expirations cited for the week of November 2, and whether released float shows up as actual selling pressure.
• DDOG’s Q3 report, scheduled before the U.S. market open on November 4, for evidence that reported software growth is holding.^[16]
• Whether AI-infrastructure demand translates into revenue and cash generation without pushing financing requirements beyond what investors will fund.
• SEC progress on Regulation NMS and fund cross-trading proposals, while keeping proposed rules separate from rules already in force.
• Earnings and demand updates from the consumer and housing-related names. In this research pass, the latest available observations varied materially in date and business context.

Bottom line: H1 2026 confirms that U.S. markets can raise substantial capital, but the quiet near-term calendar, AI-related volatility, uneven repurchase signals and still-pending rule proposals argue against equating issuance with effortless liquidity. The base case is selective financing: transactions can proceed when terms and demand align, while execution quality and aftermarket supply remain the test. This is market research, not investment advice.

Sources

• SEC, H1 2026 capital-markets statistics (September 23)
• Renaissance Capital, IPO calendar (November 2)
• Renaissance Capital, November IPO week ahead (October 30)
• Anthropic, proposed IPO filing announcement (October 26)
• SEC, proposed Regulation NMS amendments
• SEC, statement on proposed amendments to cross-trading rules (October 9)
• SEC DERA, round-lot staff paper (October 14)
• Datadog, Q2 2026 results and Q3 call announcement
• Snowflake, fiscal Q2 2027 results
• CoreWeave, Q2 2026 results
• AutoNation, Q3 2026 results
• RH, Q2 2026 shareholder letter
• Williams-Sonoma, Q2 2026 results
• Reuters report on October 30 technology-market decline